Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.5%

4 terminated/withdrawn out of 38 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed trials have results

Key Signals

11 recruiting5 with results

Enrollment Performance

Analytics

N/A
13(44.8%)
Phase 1
7(24.1%)
Phase 2
6(20.7%)
Phase 4
2(6.9%)
Phase 3
1(3.4%)
29Total
N/A(13)
Phase 1(7)
Phase 2(6)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT05264974Phase 1Recruiting

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Role: collaborator

NCT04573140Phase 1Recruiting

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Role: collaborator

NCT05322850Phase 1Suspended

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Role: collaborator

NCT06217094Phase 1Withdrawn

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Role: collaborator

NCT07359911Not ApplicableRecruiting

Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients

Role: collaborator

NCT05081882Phase 2Active Not Recruiting

Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

Role: collaborator

NCT07214584Recruiting

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Role: collaborator

NCT05015426Phase 1Active Not Recruiting

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Role: collaborator

NCT07357298Phase 3Not Yet Recruiting

Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer

Role: collaborator

NCT07031765Phase 1Active Not Recruiting

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

Role: collaborator

NCT05677360Not ApplicableSuspended

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Role: collaborator

NCT05619497Not ApplicableCompleted

The OPENS Trial: Offering Women PrEP (Aim 2)

Role: collaborator

NCT07231159Recruiting

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Role: collaborator

NCT07214883Recruiting

UCF MammoChat: Image Repository

Role: collaborator

NCT06098144Phase 4Recruiting

Smoking Cessation Program in the Construction Sector

Role: collaborator

NCT07021794Phase 2Recruiting

SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)

Role: collaborator

NCT07091058Recruiting

Harmful Algal Blooms

Role: collaborator

NCT03955991Phase 4Completed

VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)

Role: collaborator

NCT05800210Phase 2Recruiting

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

Role: collaborator

NCT05454267Recruiting

Early Detection of Vaping-related Vascular Diseases

Role: collaborator